These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25656298

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.
    Joshi AB, Banjara MR, Chuke S, Kroeger A, Jain S, Aseffa A, Reeder JC.
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011714. PubMed ID: 37943733
    [Abstract] [Full Text] [Related]

  • 26. Changing trends in visceral leishmaniasis: 10 years' experience at a referral hospital in Nepal.
    Pun SB, Sato T, Pandey K, Pandey BD.
    Trans R Soc Trop Med Hyg; 2011 Oct; 105(10):550-4. PubMed ID: 21889181
    [Abstract] [Full Text] [Related]

  • 27. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
    Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V, Picado A, Meessen B, Sundar S.
    Trop Med Int Health; 2009 Jun; 14(6):639-44. PubMed ID: 19392741
    [Abstract] [Full Text] [Related]

  • 28. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.
    Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R, Das P.
    Am J Trop Med Hyg; 2010 Sep; 83(3):502-6. PubMed ID: 20810810
    [Abstract] [Full Text] [Related]

  • 29. Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.
    Bhandari GP, Angdembe MR, Rijal S, Boelaert M.
    Nepal Med Coll J; 2011 Sep; 13(3):220-5. PubMed ID: 22808821
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.
    Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, Rijal S, Joshi A, Kroeger A, Varghese B, Thakur CP, Huda MM, Mondal D.
    Am J Trop Med Hyg; 2010 Sep; 83(3):507-11. PubMed ID: 20810811
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S, Mishra J, Gupta AK, Singh A, Shankar P, Singh S.
    Parasit Vectors; 2017 Jan 31; 10(1):49. PubMed ID: 28137296
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.
    Huda MM, Hirve S, Siddiqui NA, Malaviya P, Banjara MR, Das P, Kansal S, Gurung CK, Naznin E, Rijal S, Arana B, Kroeger A, Mondal D.
    BMC Public Health; 2012 Nov 20; 12():1001. PubMed ID: 23164318
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.